Disc Diffusion and ComASP(®) Cefiderocol Microdilution Panel to Overcome the Challenge of Cefiderocol Susceptibility Testing in Clinical Laboratory Routine

Cefiderocol susceptibility testing represents a major challenge for clinical microbiology. Although disc diffusion showed robustness to test cefiderocol susceptibility, large areas of technical uncertainty (ATU) are reported by current EUCAST breakpoints. Herein, we evaluated the in vitro activity o...

Descripción completa

Detalles Bibliográficos
Autores principales: Bianco, Gabriele, Boattini, Matteo, Comini, Sara, Banche, Giuliana, Cavallo, Rossana, Costa, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045311/
https://www.ncbi.nlm.nih.gov/pubmed/36978470
http://dx.doi.org/10.3390/antibiotics12030604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045311/
https://www.ncbi.nlm.nih.gov/pubmed/36978470
http://dx.doi.org/10.3390/antibiotics12030604

Ejemplares similares